JP Morgan's double upgrade with a 22% PT hike, just 3 days before earnings, is a strong bullish catalyst. With institutional buying accelerating and short interest elevated, AXP could see a squeeze if earnings deliver. Traders should watch for a break above $360 (near the mean target) as confirmation.
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 13 $354.43entry
- T+1 · 4mo ago +0.18%α −0.18% · $355.06
- T+5 · 4mo ago +0.26%α +1.04% · $355.35
- T+20 · 3mo ago −4.41%α −7.59% · $338.82
- T+60 · 6w ago −14.07%α −18.07% · $304.55
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
JP Morgan double upgraded AXP from Neutral to Overweight on July 13, 2026, raising the price target to $400 from $328, implying 14.1% upside from the current $350.58. The firm's 56% accuracy on 9 AXP calls and 9.5% average return rank it above average among covering analysts. Consensus is mixed: 18 Buy/Strong Buy (42%), 17 Hold (40%), 1 Sell (2%) from 36 analysts. The mean target is $371.38, median $370, with a high of $450 and low of $312. JP Morgan's new $400 target sits above the mean and median, signaling conviction. Momentum is positive with 2 upgrades and 0 downgrades in the past 30 days, though EPS revisions are slightly negative (3 up vs 5 down for the current quarter). A single insider sale of $2.4M on June 15 is a weak bearish signal, while a congressional buy in May is a minor bullish tick. Institutional buying is strong, with several funds adding or doubling positions. Short interest at 65.3% of TRF volume is elevated, suggesting potential squeeze fuel. The next earnings report is due July 16, just 3 days after this upgrade, adding timing significance. Bottom line: a high-conviction double upgrade from a 56%-accurate firm with a 9.5% average return, above-consensus PT, and strong institutional support, bullish for AXP near-term.
Impact Score
Consensus & Targets
Consensus is mixed: 5 Strong Buy, 13 Buy (42% bullish), 17 Hold (40% neutral), 0 Sell, 1 Strong Sell (2% bearish) from 36 analysts. The consensus leans slightly bullish but with a large neutral camp, making JP Morgan's double upgrade a notable contrarian push toward the bullish side.
Current price: $350.58. Mean target: $371.38, median: $370. High: $450, low: $312. Implied upside to mean: 5.9%. JP Morgan's $400 target is 7.7% above the mean and 8.1% above the median, placing it in the top quartile of analyst targets. The prior PT of $328 was below the mean; the new PT signals a significant re-rating.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-13 | JP Morgan | upgrade | Overweight | $400.00 |
| 2026-07-09 | B of A Securities | maintain | Buy | $391.00 |
| 2026-07-07 | TD Cowen | maintain | Hold | $338.00 |
| 2026-07-07 | UBS | maintain | Neutral | $386.00 |
| 2026-07-07 | Barclays | maintain | Equal-Weight | $364.00 |
| 2026-07-06 | Evercore ISI Group | maintain | In-Line | $380.00 |
| 2026-06-30 | Piper Sandler | initiate | Overweight | $396.00 |
| 2026-06-30 | BTIG | maintain | Sell | $324.00 |
| 2026-06-24 | Truist Securities | maintain | Buy | $375.00 |
| 2026-06-16 | BTIG | reiterate | Sell | $285.00 |
30-day analyst activity: 2 upgrades (JP Morgan double upgrade, Piper Sandler initiate Overweight), 0 downgrades. EPS revisions are mixed: current quarter has 3 upward revisions vs 5 downward in the past 30 days, but the current EPS estimate of $4.40498 is slightly above the 30-day-ago estimate of $4.38435. Full-year 0y estimates show 4 up vs 4 down revisions, with the current estimate of $17.74912 above the 30-day-ago $17.68787. Overall, estimates are stabilizing with a slight upward bias.
Firm Track Record: JP Morgan
JP Morgan accuracy: 55% on 5701 calls | avg return: 5.6%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| TD Cowen | 100% | 2/2 | 11.5% | top tier |
| Goldman Sachs | 100% | 2/2 | 11.9% | top tier |
| Deutsche Bank | 100% | 2/2 | 11.5% | top tier |
| Barclays | 86% | 6/7 | 10.4% | top tier |
| Evercore ISI Group | 83% | 5/6 | 4.7% | top tier |
| Monness, Crespi, Hardt | 80% | 4/5 | 9.6% | top tier |
| Citigroup | 75% | 3/4 | 0.7% | top tier |
| Truist Securities | 75% | 6/8 | 6.2% | top tier |
| B of A Securities | 71% | 5/7 | 13% | top tier |
| RBC Capital | 71% | 5/7 | 6.4% | top tier |
JP Morgan has 56% accuracy on 9 AXP calls with a 9.5% average return, ranking above average among covering firms. The best-performing firms on AXP are TD Cowen, Goldman Sachs, and Deutsche Bank (all 100% on 2 calls each). The worst are UBS and Keefe, Bruyette & Woods (50% on 2 and 6 calls, respectively). JP Morgan's track record is solid but not elite, making this double upgrade a meaningful but not top-tier signal.
Earnings Estimates
Next earnings: Jul 16, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $4.40 | $4.18 to $4.70 | $19.7B | ↑3 ↓0 |
| +1q | $4.69 | $4.43 to $5.64 | $20.1B | ↑1 ↓0 |
| 0y | $17.75 | $17.04 to $18.71 | $79.5B | ↑3 ↓0 |
| +1y | $20.15 | $19.30 to $20.88 | $86.5B | ↑2 ↓0 |
Cross-Platform Signals
Insider activity: one SELL by McNeal Glenda G on June 15 for $2.4M, a weak bearish signal per academic literature (insider sales are often liquidity-driven). Congressional activity: one buy by Rep. Rick Allen (R) on May 8 for $1K-$15K, a minor bullish tick. Institutional changes are strongly bullish: 5 funds added or doubled positions, including ABN AMRO (+1,384%), Empowered Funds (+189%), and Integrated Wealth Concepts (+79%). Short interest is elevated at 65.3% of TRF volume, suggesting potential squeeze risk. The analyst signal converges with institutional buying and diverges from the insider sale (which is weak). Overall, cross-platform signals are bullish.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
44 reports on AXP
6 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +11.61% at T+60 after the Apr 23, 2026 report. 9 of 10 went positive at some point.
Filters
- Nov 16, 2026today 8-K Neutral 2/10 Entry $319.25 Now $319.05 −0.06% settles Nov 23
- Nov 12, 20265d ago Court Ruling Neutral 1/10 Entry $320.60 Now $319.05 −0.48% settles Nov 20
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $324.31 to $319.05 Now $319.05 −1.62% ▼ −1.62% +0.07% vs SPY
- Nov 4, 202612d ago 144 Bearish 5/10 Entry $324.97 to $318.06 Now $319.05 +1.82% ▲ +2.13% +5.42% vs SPY
- Nov 3, 202613d ago Insider Cluster Neutral 3/10 Entry $332.59 to $323.11 Now $319.05 −4.07% ▼ −2.85% −1.94% vs SPY
- Nov 2, 202614d ago 144 Neutral 4/10 Entry $325.50 to $323.46 Now $319.05 −1.98% ▼ −0.63% −0.04% vs SPY
- Oct 30, 202617d ago 8-K Neutral 2/10 Entry $319.11 to $320.99 Now $319.05 −0.02% ▲ +0.59% +3.29% vs SPY
- Oct 29, 202618d ago Institutional Cluster Bullish 4/10 Entry $323.71 to $324.97 Now $319.05 −1.44% ▲ +0.39% +5.12% vs SPY
- Oct 23, 202624d ago 8-K Bullish 7/10 Entry $313.22 to $319.11 Now $319.05 +1.86% ▲ +1.88% +2.44% vs SPY
- Oct 15, 20264w ago 8-K Neutral 3/10 Entry $313.87 to $325.17 Now $319.05 +1.65% ▲ +3.60% +4.61% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers